Non-HLA lymphocytotoxic antibodies during GVHD after bone marrow transplantation (BMT)
Gluckman, E.; Andersen, E.; Lepage, V.; Dausset, J.
Transplantation Proceedings 9(1): 761-763
1977
ISSN/ISBN: 0041-1345 PMID: 17200 Document Number: 110357
Document emailed within 1 workday
Related Documents
Antica, M.; Hoffmann-Fezer, G.; Thierfelder, S. 1989: Antilymphocytic antibodies and marrow transplantation. IX. T-cell depletion in marrow donors with C1q high and low affinity antibodies for suppression of GVHD in fully mismatched mice Experimental Hematology 17(9): 942-947Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
Blaise, D.; Guyotat, D.; Reiffers, J.; Olive, D.; Michallet, M.; Bellanger, C.; Vernant, J.P.; Ifrah, N.; Attal, M.; Vilmer, E. 1991: Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT) Bone Marrow Transplantation 7 Suppl. 2: 150
Topolsky, D.; Crilley, P.; Styler, M.J.; Bulova, S.; Brodsky, I.; Marks, D.I. 1996: Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD Bone Marrow Transplantation 17(4): 549-554
Hassan, H.T.; Krog, C.; Stockschläder, M.; Schleimer, B.; Zeller, W.; Krüger, W.; Erttmann, R.; Zander, A.R. 1997: Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience Anticancer Research 17(1b): 589-599
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Ball, E.D. 1988: In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies Bone Marrow Transplantation 3(5): 387-392
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
León-Rodríguez, E.; Sosa Sánchez, R.; Gómez, E.; Ochoa Sosa, C. 1993: Bone marrow transplantation in aplastic anemia. Experience at a Mexican institution. Bone marrow transplantation group of the Salvador Zubirán National Institute of Nutrition Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 45(6): 559-564
Gassmann, W.; von Kolszynski, M.; Wottge, H.U.; Müller-Ruchholtz, W. 1987: Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation Transplantation Proceedings 19(1 Part 3): 2687-2688
Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470
Locasciulli, A.; Alberti, A.; de Bock, R.; Cordonnier, C.; Einsele, H.; Engelhard, D.; Grundy, J.; Reusser, P.; Ribaud, P.; Ljungman, P. 1994: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party Bone Marrow Transplantation 14(5): 833-837
Nakayama, H.; Okamura, J.; Ikuno, Y.; Shigeno, K.; Tasaka, H. 1992: Isolated renal relapse after bone marrow transplantation in childhood leukemia. Bone Marrow Transplantation Team Bone Marrow Transplantation 10(2): 195
Mañez, R.; Kobayashi, M.; Takaya, S.; Bronsther, O.; Kramer, D.; Bonet, H.; Iwaki, Y.; Fung, J.J.; Demetris, A.J.; Starzl, T.E. 1993: Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation Transplantation Proceedings 25(1 Part 2): 888-890
Duhamel, G.; Gorin, N.C.; Douay, L.; Najman, A.; Stachowiak, J. 1982: Bone marrow repopulation after heavy chemotherapy and autologous bone marrow transplantation. Monitoring with biopsies and marrow culture on agar La Nouvelle Presse Medicale 11(11): 833-836
De Witte, T.; Zwaan, F.; Hermans, J.; Vernant, J.; Kolb, H.; Vossen, J.; Lönnqvist, B.; Beelen, D.; Ferrant, A.; Gmür, J. 1989: Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Bone Marrow Transplantation 4(Suppl 3): 38-39
Májský, A. 1992: Anti-idiotype antibodies to specific HLA. Incidence after bone marrow transplantation. Specificity and binding activity Vnitrni Lekarstvi 38(7): 678-684
Janitschke, K.; Held, T.; Kr, D.üger; Schwerdtfeger, R.; Schlier, G.; Liesenfeld, O.. 2003: Diagnostic Value of Tests for Toxoplasma gondii-specific Antibodies in Patients Undergoing Bone Marrow Transplantation Clinical Laboratory 49(5-6): 239-242